Scott Tagawa, MD

Articles by Scott Tagawa, MD

Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial

ByScott Tagawa, MD,Aislinn Antrim, Managing Editor

November 14th 2025

Scott Tagawa, MD, professor of medicine and urology at Weill Cornell Medicine, discusses safety and tolerability findings observed to date, renal and hematologic considerations, and the role of pharmacists.

Lutetium-177 PSMA-617 Plus ADT and ARPI Improves Progression-Free Survival in PSMAddition Trial

ByScott Tagawa, MD

November 12th 2025

New research highlights the benefits of combining lutetium PSMA 617 with standard treatments, showing improved outcomes for prostate cancer patients.

Scott Tagawa, MD

Articles by Scott Tagawa, MD

Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial

Lutetium-177 PSMA-617 Plus ADT and ARPI Improves Progression-Free Survival in PSMAddition Trial

Latest Updated Articles

Trending on Pharmacy Times

A Healthy Gut Could Improve Mental Health

FDA Approves First Oral GLP-1 for Weight Management

December 2025 Product Updates

FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia

Reimagining Pharmacy: A Call to Action for Pharmacy Professionals